
FDA SAFETY SURVEILLANCE OF COVID-19 VACCINES :
DRAFT WORKING LIST OF POSSIBLE ADVERSE EVENT OUTCOMES
SUBJECT TO CHANGE
Guillain-Barré syndrome
Acute disseminated encephalomyelitis
Transverse myelitis
Encephalitis/myelitis/encephalomyelitis/ meningoencephalitis/meningitis/encepholapathy
Convulsions/seizures
Stroke
Narcolepsy and cataplexy
Anaphylaxis
Acute myocardial infarction
Myocarditis/pericarditis
Autoimmune disease
Deaths
Pregnancy and birth outcomes
Other acute demyelinating diseases
Non-anaphylactic allergic reactions
Thrombocytopenia
Disseminated intravascular coagulation
Venous thromboembolism
Arthritis and arthralgia/joint pain
Kawasaki disease
Multisystem Inflammatory Syndrome in Children
Vaccine enhanced disease
READ THE REST:
VERY INTERESTING LISTS #VIL 2: FDA EXPECTS THESE ADVERSE REACTIONS TO COVID JABS. SINCE OCTOBER 2020
Add New Post
SavedPreview(opens in a new tab)Add titleFDA SAFETY SURVEILLANCE OF COVID-19 VACCINES : DRAFT Working list of possible adverse event outcomes – October 22, 2020 – *****THEY KNEW*****